BridgeMD
Prevention study for Mild Cognitive Impairment
Official title Effectiveness of Non-pharmacological Interventions for Dementia Prevention in Elderly Patients With Mild Cognitive Impairment
ClinicalTrials.gov ID: NCT06453746
What this study is testing
- What it's testing
- The aims of this study is to evaluate the effectiveness of non-pharmacological interventions program in preventing progression from mild cognitive impairment to dementia in patients with mild cognitive impairment in the short term, at Nhân dân Gia Định Hospital, Hồ Chí Minh City.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- people diagnosed with mild cognitive impairment:
- Cognitive complaints from the subject or a family member.
- Report a decline in cognitive function compared to the subject's previous ability over the past year OR
- Evidence from clinical assessment, specifically here is MMSE screening with results of 24-29 points.
- people did not suffer major impacts from cognitive complaints on daily life.
You likely can't join if
- Don't know Vietnamese writing.
- Audio-visual ability does not meet the requirements of assessment tests and prevention programs.
- Systemic diseases are contraindications/ restriction to participation in programs and/or cause secondary cognitive impairment (traumatic brain...
- The assessment score on the Geriatric Depression Scale (GDS-15) is ≥ 5 points.
- Diagnosed with other mental disorders that may limit the ability to understand, communicate and work in groups (schizophrenia, mania, bipolar...
- Currently participating in another research program on dementia prevention or a research program on medication to prevent dementia within the last 3...
See the full eligibility criteria
- people diagnosed with mild cognitive impairment:
- Cognitive complaints from the subject or a family member.
- Report a decline in cognitive function compared to the subject's previous ability over the past year OR
- Evidence from clinical assessment, specifically here is MMSE screening with results of 24-29 points.
- people did not suffer major impacts from cognitive complaints on daily life.
- No prior diagnosis of dementia.
- Ensure transportation from living location to hospital.
- Have at least one relative or caregiver who can supervise the subject's daily activities.
- Stable chronic underlying conditions (diabetes, hypertension).
- Consent to participate in the study.
- Don't know Vietnamese writing.
- Audio-visual ability does not meet the requirements of assessment tests and prevention programs.
- Systemic diseases are contraindications/ restriction to participation in programs and/or cause secondary cognitive impairment (traumatic brain injury, stroke, brain tumor, parkinsonism, epilepsy, acute coronary artery...
- The assessment score on the Geriatric Depression Scale (GDS-15) is ≥ 5 points.
- Diagnosed with other mental disorders that may limit the ability to understand, communicate and work in groups (schizophrenia, mania, bipolar disorder, dissociative disorder, generalized anxiety disorder).
- Currently participating in another research program on dementia prevention or a research program on medication to prevent dementia within the last 3 months.
- Taking medications that may affect cognitive function, such as benzodiazepines, hypnotics, and antipsychotics.
- Alcohol abuse: drinking alcohol daily or consuming more than 14 units of alcohol per week (equivalent to 10 grams of ethanol, as defined by the Ministry of Health); diagnosed with alcohol dependence or currently being...
- Do not agree to participate in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Ho Chi Minh City, Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ho Chi Minh City, Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.